In the present study, we report that TRPC6 (11q22) is overexpressed in HNSCC, and provide new evidence that increase in gene dosage is a novel mechanism to activate TRPC6 expression in cancer. The gene discussed is TRPC6; the disease is head and neck squamous cell carcinoma.